X0306 4 2017-02-14 0 0000816284 CELGENE CORP /DE/ CELG 0001232505 HUGIN ROBERT J C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 1 1 0 0 see remarks Phantom Stock 2017-02-14 4 A 0 28510 A Common Stock 28510 28510 D Each share of phantom stock represents a right to receive one share of common stock. The phantom stock becomes payable six months following the reporting person's termination of employment with Celgene Corporation. The reporting person was awarded 28,510 shares of common stock pursuant to the 2014-2016 Long Term Incentive Plan under the Celgene Corporation 2008 Stock Incentive Plan (Amended and Restated as of April 15, 2015). The reporting person deferred the receipt of such 28,510 shares of common stock and received instead 28,510 shares of phantom stock pursuant to the Celgene Corporation 2005 Deferred Compensation Plan. Executive Chairman /s/ Robert J. Hugin 2017-02-16